AKT1 and acute lymphoblastic leukemia: Combining BEZ235 with dexamethasone in acute lymphoblastic leukemia (ALL) showed that along with inhibiting the PI3K/AKT/mTOR pathway, antileukemic effects of dexamethasone were improved in vitro and in vivo.